- Home
- TOUR vs TARA Comparison
TOUR vs TARA Comparison
Compare TOUR & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOUR
- TARA
- Stock Information
- Founded
- TOUR 2006
- TARA N/A
- Country
- TOUR China
- TARA United States
- Employees
- TOUR N/A
- TARA N/A
- Industry
- TOUR Transportation Services
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TOUR Consumer Discretionary
- TARA Health Care
- Exchange
- TOUR Nasdaq
- TARA Nasdaq
- Market Cap
- TOUR 98.6M
- TARA 118.1M
- IPO Year
- TOUR 2014
- TARA N/A
- Fundamental
- Price
- TOUR $0.85
- TARA $3.15
- Analyst Decision
- TOUR
- TARA Strong Buy
- Analyst Count
- TOUR 0
- TARA 6
- Target Price
- TOUR N/A
- TARA $19.80
- AVG Volume (30 Days)
- TOUR 227.2K
- TARA 175.3K
- Earning Date
- TOUR 08-15-2025
- TARA 08-11-2025
- Dividend Yield
- TOUR 4.26%
- TARA N/A
- EPS Growth
- TOUR N/A
- TARA N/A
- EPS
- TOUR 0.03
- TARA N/A
- Revenue
- TOUR $75,532,120.00
- TARA N/A
- Revenue This Year
- TOUR $16.99
- TARA N/A
- Revenue Next Year
- TOUR $13.23
- TARA N/A
- P/E Ratio
- TOUR $25.62
- TARA N/A
- Revenue Growth
- TOUR 7.57
- TARA N/A
- 52 Week Low
- TOUR $0.75
- TARA $1.60
- 52 Week High
- TOUR $1.76
- TARA $10.48
- Technical
- Relative Strength Index (RSI)
- TOUR 56.42
- TARA 55.78
- Support Level
- TOUR $0.82
- TARA $3.04
- Resistance Level
- TOUR $0.85
- TARA $3.31
- Average True Range (ATR)
- TOUR 0.05
- TARA 0.16
- MACD
- TOUR 0.01
- TARA 0.01
- Stochastic Oscillator
- TOUR 82.00
- TARA 81.94
About TOUR Tuniu Corporation
Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. It offers a large selection of packaged tours, including organized tours and self-guided tours, as well as travel-related services for leisure travelers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. The company derives almost all of its revenue from PRC.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).